Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe primary condition label 'Multiple myeloma' and the related topics section (including MedlinePlus Genetics) were removed from the page. This changes what the page presents about the study’s condition and the available educational links.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also shows that recruitment is closed ('No longer looking for participants') and updates the revision version to v3.6.0 (replacing v3.5.5).SummaryDifference0.5%

- Check17 days agoChange DetectedThe page now references Multiple myeloma as a study context and includes a related topics link to MedlinePlus Genetics, enriching the study's topical scope and external resources. The metadata revision was updated to v3.5.5 (replacing v3.5.4).SummaryDifference0.2%

- Check38 days agoChange DetectedNew revision label Revision: v3.5.4 was added. An older revision (v3.5.3) and several topic references, including Multiple myeloma and MedlinePlus Genetics, were removed.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record adds new keywords and related-topic references, including 'Multiple myeloma' and a 'related topics' label, plus a link to 'MedlinePlus Genetics' for additional context. This provides extra context links without changing the core trial information.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the study record details.SummaryDifference0.1%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.